Acute phase reactants and clinical stages in multiple myeloma

Area of Science:

• Clinical Chemistry
• Hematology
• Oncology

Background:

• Multiple myeloma is a plasma cell malignancy.
• Acute phase reactants (APRs) are proteins whose plasma concentrations increase or decrease post-trauma or infection.
• Understanding serum protein profiles in multiple myeloma is crucial for diagnosis and monitoring.

Purpose of the Study:

• To investigate serum levels of seven specific proteins, primarily APRs, in multiple myeloma patients.
• To compare these levels with those in healthy controls.
• To explore potential differences in APRs across multiple myeloma subtypes.

Main Methods:

• Serum samples were collected from 14 healthy subjects and 55 patients with multiple myeloma.
• Levels of seven proteins (transferrin, alpha 2-macroglobulin, alpha 1-antitrypsin, haptoglobin, C3, ceruloplasmin, orosomucoid) were measured.
• Statistical analysis was performed to compare protein levels between groups and across myeloma subclasses.

Main Results:

• Multiple myeloma patients showed significantly decreased levels of alpha 2-macroglobulin and transferrin compared to controls.
• Orosomucoid and ceruloplasmin levels were significantly elevated in myeloma patients.
• Distinct APR patterns were observed in IgG3 and IgA myeloma subtypes, with some positive APRs showing decreased levels in IgA myeloma.

Conclusions:

• Serum transferrin and haptoglobin levels may serve as novel parameters for calculating IgA myeloma cell mass.
• Specific APR profiles can differentiate between multiple myeloma subtypes.
• These findings contribute to a better understanding of the biochemical alterations in multiple myeloma.